Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

A new engineered treatment shows promise in curing heart fibrosis.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Abrocitinib may effectively treat Lichen Planopilaris.

Certain plant compounds can help prevent and treat a virus in pigs.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.